G9547 – Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols

Long description

Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols

Short description

Cys ren les or adren

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2016

Last change

January 1, 2020 – No change

Nearby G codes

• G9537 – Imaging needed as part of a clinical trial; or other clinician ordered the study
• G9538 – Advanced brain imaging (cta, ct, mra or mri) was ordered
• G9539 – Intent for potential removal at time of placement
• G9540 – Patient alive 3 months post procedure
• G9541 – Filter removed within 3 months of placement
• G9542 – Documented re-assessment for the appropriateness of filter removal within 3 months of placement
• G9543 – Documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement
• G9544 – Patients that do not have the filter removed, documented re-assessment for the appropriateness of filter removal, or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement
• G9548 – Final reports for imaging studies stating no follow-up imaging is recommended
• G9549 – Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadenopathy, signs of metastasis or an active diagnosis or history of cancer, and other medical reason(s))
• G9550 – Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up
• G9551 – Final reports for imaging studies without an incidentally found lesion noted
• G9552 – Incidental thyroid nodule < 1.0 cm noted in report
• G9553 – Prior thyroid disease diagnosis
• G9554 – Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging recommended
• G9555 – Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))